UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti‐tumor CTL and TH1 cytokine responses by B cells

International journal of cancer, 2005-11, Vol.117 (4), p.574-586

2005

Link zum Volltext

Verfügbarkeit prüfen

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

Cancer Immunology, Immunotherapy, 2013-01, Vol.62 (1), p.87-99

2013

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases

Cells (Basel, Switzerland), 2021-10, Vol.10 (11), p.2904

2021

Link zum Volltext

Verfügbarkeit prüfen

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24), p.10121-10130

2010

Link zum Volltext

Verfügbarkeit prüfen

Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell–dependent cytotoxicity

Blood, 2017-04, Vol.129 (16), p.2246-2256

2017

Link zum Volltext

Verfügbarkeit prüfen

An Anti-Transferrin Receptor-Avidin Fusion Protein Exhibits Both Strong Proapoptotic Activity and the Ability to Deliver Various Molecules into Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2002-08, Vol.99 (16), p.10706-10711

2002

Link zum Volltext

Verfügbarkeit prüfen

An Antibody-Avidin Fusion Protein Specific for the Transferrin Receptor Serves as a Delivery Vehicle for Effective Brain Targeting: Initial Applications in Anti-HIV Antisense Drug Delivery to the Brain

The Journal of immunology (1950), 1999-10, Vol.163 (8), p.4421-4426

1999

Link zum Volltext

Verfügbarkeit prüfen

Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses

International immunology, 2016-09, Vol.28 (9), p.423-433

2016

Link zum Volltext

Verfügbarkeit prüfen

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein

Molecular cancer therapeutics, 2005-06, Vol.4 (6), p.956-967

2005

Link zum Volltext

Verfügbarkeit prüfen

Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy

Molecular cancer therapeutics, 2011-04, Vol.10 (4), p.603-614

2011

Link zum Volltext

Verfügbarkeit prüfen

Model for in vivo progression of tumors based on co-evolving cell population and vasculature

Scientific reports, 2011-07, Vol.1 (1), p.31, Article 31

2011

Link zum Volltext

Verfügbarkeit prüfen

Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her‐2/neu antigen

International journal of cancer, 2002-12, Vol.102 (4), p.428-434

2002

Link zum Volltext

Verfügbarkeit prüfen

Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction

Cancer Immunology, Immunotherapy, 2008-05, Vol.57 (5), p.663-675

2008

Link zum Volltext

Verfügbarkeit prüfen

[32] Production and properties of chimeric antibody molecules

Methods in Enzymology, 1989, Vol.178, p.459-476

1989

Link zum Volltext

Verfügbarkeit prüfen

Expression and Characterization of an Antibody Binding Specificity Joined to Insulin-Like Growth Factor 1: Potential Applications for Cellular Targeting

Proceedings of the National Academy of Sciences - PNAS, 1990-07, Vol.87 (14), p.5322-5326

1990

Link zum Volltext

Verfügbarkeit prüfen

The Pharmacokinetics of Heroin in Patients with Chronic Pain

The New England journal of medicine, 1984-05, Vol.310 (19), p.1213-1217

1984

Link zum Volltext

Verfügbarkeit prüfen

Transferrin-Antibody Fusion Proteins are Effective in Brain Targeting

Proceedings of the National Academy of Sciences - PNAS, 1995-03, Vol.92 (7), p.2820-2824

1995

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the antitumor efficacies of Her-2/ neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice

Vaccine, 2003-01, Vol.21 (5), p.521-531

2003

Link zum Volltext

Verfügbarkeit prüfen

Functional properties of antibody insulin-like growth factor fusion proteins

The Journal of biological chemistry, 1994-02, Vol.269 (7), p.4979-4985

1994

Link zum Volltext

Verfügbarkeit prüfen

Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents

Update on cancer therapeutics, 2006-06, Vol.1 (2), p.159-173

2006

Link zum Volltext

Verfügbarkeit prüfen

Functional and pharmacokinetic properties of antibody-avidin fusion proteins

The Journal of immunology (1950), 1997-05, Vol.158 (10), p.4797

1997

Link zum Volltext

Verfügbarkeit prüfen

A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate Via the T Cell Costimulatory Pathway

The Journal of immunology (1950), 1998-04, Vol.160 (7), p.3419-3426

1998

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2654: Inhibition of lymphoma interactions withangiogenic and lymphangiogenic endotheliumusing αCD20-IgG1-huEndoP125A, an anti-CD20 endostatin fusion protein

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2654-2654

2023

Link zum Volltext

Verfügbarkeit prüfen

A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors

Human antibodies, 2001, Vol.10 (1), p.43

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6319: Mechanism of anti-EGFR antibody endostatin fusion protein action on inhibition of vasculogenic mimicry and tumor cell motility in triple negative breast cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6319-6319

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(57)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Animals
(33)
Science & Technology
(29)
Mice
(26)
Humans
(25)
Life Sciences & Biomedicine
(24)
Biological And Medical Sciences
(16)
Fundamental And Applied Biological Sciences. Psychology
(11)
Mice, Inbred Balb C
(11)
Cell Line
(10)
Female
(10)
Immunology
(10)
Immunotherapy
(9)
Genes, Immunoglobulin
(7)
Immunoglobulin G - Genetics
(7)
Oncology
(7)
Rats
(7)
Receptor, Erbb-2 - Immunology
(7)
Antibodies
(6)
Antibodies - Genetics
(6)
Flow Cytometry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti‐tumor CTL and TH1 cytokine responses by B cells

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response

Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell–dependent cytotoxicity

An Anti-Transferrin Receptor-Avidin Fusion Protein Exhibits Both Strong Proapoptotic Activity and the Ability to Deliver Various Molecules into Cancer Cells

An Antibody-Avidin Fusion Protein Specific for the Transferrin Receptor Serves as a Delivery Vehicle for Effective Brain Targeting: Initial Applications in Anti-HIV Antisense Drug Delivery to the Brain

Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein

Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy

Model for in vivo progression of tumors based on co-evolving cell population and vasculature

Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her‐2/neu antigen

Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction

[32] Production and properties of chimeric antibody molecules

Expression and Characterization of an Antibody Binding Specificity Joined to Insulin-Like Growth Factor 1: Potential Applications for Cellular Targeting

The Pharmacokinetics of Heroin in Patients with Chronic Pain

Transferrin-Antibody Fusion Proteins are Effective in Brain Targeting

Comparison of the antitumor efficacies of Her-2/ neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice

Functional properties of antibody insulin-like growth factor fusion proteins

Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents

Functional and pharmacokinetic properties of antibody-avidin fusion proteins

A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate Via the T Cell Costimulatory Pathway

Abstract 2654: Inhibition of lymphoma interactions withangiogenic and lymphangiogenic endotheliumusing αCD20-IgG1-huEndoP125A, an anti-CD20 endostatin fusion protein

A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors

Abstract 6319: Mechanism of anti-EGFR antibody endostatin fusion protein action on inhibition of vasculogenic mimicry and tumor cell motility in triple negative breast cancer

Suchergebnisse filtern